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Site-Selective Functionalization of (sp3)C@H Bonds Catalyzed by
Artificial Metalloenzymes Containing an Iridium-Porphyrin Cofactor
Yang Gu, Sean N. Natoli, Zhennan Liu, Douglas S. Clark und John F. Hartwig*
Abstract: The selective functionalization of one C@H bond
over others in nearly identical steric and electronic environ-
ments can facilitate the construction of complex molecules. We
report site-selective functionalizations of C@H bonds, differ-
entiated solely by remote substituents, catalyzed by artificial
metalloenzymes (ArMs) that are generated from the combi-
nation of an evolvable P450 scaffold and an iridium-porphyrin
cofactor. The generated systems catalyze the insertion of
carbenes into the C@Hbonds of a range of phthalan derivatives
containing substituents that render the two methylene positions
in each phthalan inequivalent. These reactions occur with site-
selectivity ratios of up to 17.8:1 and, in most cases, with pairs of
enzyme mutants that preferentially form each of the two
constitutional isomers. This study demonstrates the potential of
abiotic reactions catalyzed by metalloenzymes to functionalize
C@H bonds with site selectivity that is difficult to achieve with
small-molecule catalysts.
Introduction
C@H bond functionalization has changed the logic of
chemical synthesis by enabling the direct addition of func-
tional groups to a wide range of available starting materials.[1]
Small-molecule transition-metal catalysts can lead to site-
selective C@H bond functionalization,[2] but many of the
strategies for achieving selectivity rely on localized steric
effects, directing groups, or both. Thus it is challenging for
small-molecule catalysts to distinguish between C@H bonds
with similar local steric and electronic properties rendered
inequivalent by the lack of symmetry of a molecule. However,
enzymes, such as cytochromes P450 (CYPs), catalyze the
oxidation of C@H bonds that are nearly equivalent with high
site selectivity.[3] Such reactions often occur within the
biosynthetic pathways of complex natural products, such as
terpenes, alkaloids, or steroids, all of which contain an
abundance of similar C@H bonds.[4]
Although they can react with high selectivity, natural
enzymes install a limited range of functional groups during
biosynthesis. One strategy to expand the scope of reactions
catalyzed by enzymes and improve the efficiency by which
these reactions can occur is to conduct directed evolution.
Directed evolution has proven to be a powerful methodology
that allows chemists to extend the fitness of biocatalysts
toward unnatural reactions,[5] Through directed evolution, in
which many rounds of iterative mutagenesis are conducted,
hemoproteins have been repurposed to catalyze a range of
unnatural group transfer reactions to C@Cmultiple bonds and
C@H bonds with high activity and selectivity.[6]
A complementary strategy to expand the scope of known
abiological transformations is to construct artificial metal-
loenzymes (ArMs). These systems incorporate unnatural
cofactors into evolvable protein scaffolds,[7] and the resulting
ArMs are capable of catalyzing abiological reactions, often
with high selectivity. Several ArMs have been constructed by
exploiting the biotin-streptavidin interaction,[8] unnatural
amino acid anchoring,[9] and formal replacement of the native
heme cofactor with synthetic porphyrin cofactors containing
noble metals.[10]
Our laboratory reported the first example of enzymatic
carbene insertions into (sp3) C@H bonds, including intermo-
lecular functionalizations. These reactions were catalyzed by
artificial metalloenzymes containing an Ir(Me)-MPIX cofac-
tor,[11] and such reactivity provides a platform to evaluate
whether Ir(Me)-containing ArMs could be evolved to cata-
lyze site-selective reactions of C@H bonds that are nearly
equivalent and are known to yield a mixture of products with
small-molecule catalysts.[12] Phthalan derivatives were chosen
as model substrates because they have two sites that contain
(sp3) C@H bonds with similar steric and electronic environ-
ments because unsubstituted phthalan undergoes reaction
with carbene precursors catalyzed by a P450 containing the
Ir(Me)-MPIX cofactor (Scheme 1).[11]
Here, we report that 4-substituted phthalans react to give
products that are distinguished only by the position of
a remote substituent and react with pairs of Ir(Me)-contain-
ing CYP119 mutants to give one of the two opposite
constitutional isomers as the major product for most of the
derivatives. We also show that the reactions occur with high
chemoselectivity for C@H bonds over typically reactive
functional groups, such as N@H bonds, and in select cases
with high enantioselectivity.
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Results and Discussion
Reactivity of the Free Ir(Me)-MPIX Cofactor and Engineered
Ir(Me)-Hemoproteins
To determine the role of the protein scaffold in controlling
site selectivity, we first assessed the reactivity and site
selectivity of the free Ir(Me)-MPIX cofactor for the insertion
of the carbene from ethyl 2-diazoacetate (EDA) into the C@H
bond of a 4-substituted phthalan. To do so, we studied the
reaction of 4-bromophthalan (1a) with EDA catalyzed by the
free cofactor Ir(Me)-MPIX in NaPi buffer (100 mm, pH 6.0).
Without the protein, the free cofactor reaction gave a mixture
of products resulting from single and double insertion of the
carbene into the (sp3) C@H bonds of 1a. Products from
a single insertion into the C@H bonds located meta and para
to the bromine atom were observed in a 1:1 ratio (Scheme 2).
Selective carbene insertions into (sp3) C@H bonds catalyzed
by transition-metal catalysts typically involve the use of
a donor–acceptor carbene precursor.[13] There are only a few
small-molecule catalysts that effect insertions of acceptor-
only carbenes into C@H bonds, and they require the substrate
as a solvent or in excess (Scheme 1A).[12, 14] We reasoned that
the pre-organization of substrates within the active site of
a protein would afford the opportunity to catalyze site-
selective intermolecular C@H functionalization using the
substrates as the limiting reagents.
To test the ability of engineered Ir(Me) hemoproteins to
differentiate nearly identical C@H bonds and to yield
products from insertion of a carbene into just one C@H bond,
we conducted reactions of 4-bromophthalan 1a and EDA
with previously engineered myoglobin (Myo) mutants. Eval-
uation of site selectivity from reactions catalyzed by over one-
hundred Ir(Me) Myo mutants,[10b,d] containing mutations over
six active-site residues, from clarified lysate and purified
protein reaction screening did not uncover any notable site
selectivity beyond that of the free cofactor.
On the basis of our previous studies on artificial metal-
loenzymes generated from artificial cofactors and CYP119,
a P450 from the thermophile Sulfolobus solfataricus, we
investigated whether selectivity could be obtained from this
scaffold, which possesses a more enclosed active site. We
previously showed that the melting temperature of CYP119 is
higher (69 8C) than that for the analogous construct from the
more commonly studied P450-BM3 (45 8C),[11] and that
carbene insertions into C@H bonds do not require the
reductase domain contained within BM3.
We initially screened for selectivity with T213G,C317G,
a double mutant in which both the size and hydrogen-bonding
ability of the amino acid residue at position 213 are reduced
and the native axial heme-ligating cysteine at position 317 is
eliminated. In contrast to reactions of the free cofactor, the
reactions catalyzed by the double mutant CYP119 enzyme
gave only product from insertion of a single carbene
(Scheme 2). Although the site selectivity from this initial
experiment was negligible, the improved chemoselectivity for
a single insertion product was clearly imparted by the protein
environment.
Directed Evolution of Ir(Me)-CYP119
To create catalysts for site-selective C@H functionaliza-
tion of phthalan derivatives, we studied the reaction of 4-
bromophthalan 1a with EDA catalyzed by a mutant library of
CYP119 proteins.[11] This library was constructed from the
double-mutant scaffold containing the T213G and C317G
mutations, with the introduction of additional mutations at
Scheme 1. Intermolecular insertion of acceptor-only carbenes into
(sp3)C@H bonds with small-molecule catalysts and biocatalysts.
Scheme 2. Site-selective intermolecular C@H insertion catalyzed by
Ir(Me)-MPIX. Yields refers to the formation of all the carbene insertion
products and were determined by GC with dodecane as the internal
stander.
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amino acids proximal to the active site (Figure 1). The mutant
library was evaluated by screening in 96-well plates. Reac-
tions were conducted by generating Ir(Me)-MPIX CYP119 in
cell lysate by reconstituting each apo-protein mutant variant
with a stock solution of Ir(Me)-MPIX cofactor, followed by
adding stock solutions of the phthalan and carbene precursor
catalyst stock solutions to the 96-well plates. The ratios of
isomeric products from the insertion process were measured
by high-throughput GC sampling from the 96-well plates.
Results from these experiments indicated that some
members of the CYP119 mutant library catalyze reactions
at one of the two methylene positions of the substituted
phthalan with measurable selectivity. For example, the
mutant of CYP119-PG1 (para generation 1: C317G, T213G,
V254L, A152F) preferentially formed the product from
insertion into the benzylic C@H bond para to the bromine
atom over that from insertion meta to the bromine atom with
a 2.8:1 ratio and 720 turnover numbers (TON). In contrast,
the mutant of CYP119-MG1(meta generation 1: C317G,
T213G, V254A, A152L) preferentially formed the product
from insertion into the benzylic C@H bond meta to the
bromine atom with a 1:2.7 ratio and 690 TON (Scheme 2).
Reactions conducted at catalyst loadings lower than
0.05 mol% led to lower conversion, but they also led to
lower site selectivity and gave a mixture of products resulting
from a single and double insertion of the carbene into the
(sp3) C@H bonds of 1a. We assumed the lower chemo- and
site selectivity results from an instability of the Ir(Me)-bound
CYP119 construct to the reaction conditions, leading to the
generation of free cofactor. This decomposition presumably
also influences reactions at higher catalyst loadings. Because
the proteins at this point of the evolution were generated by
mutagenesis only in the active site, we created a new library of
mutants based on PG1 andMG1 by error-prone PCR that would
contain mutations distal to the active site that could stabilize
the Ir(Me)-bound P450 construct.
Indeed, three rounds of error-prone PCR led to enzymes
that catalyzed the carbene transfer with greater site selectiv-
ity, in many cases reaching differences in selectivity greater
than 10:1 between pairs of mutants reacting at the two
methylene positions of 1a and with higher turnovers. Eleven
mutants were identified that catalyze the reaction to form
predominantly the para isomer, and 10 mutants were
identified that preferentially form the meta isomer. These 21
mutants that reacted with selectivity higher than those of the
parent mutants were tested for activity across a series of 4-
substiuted phthalan derivatives, with which small transition-
metal complexes,[12] including the free Ir(Me)-MPIX cofactor,
reacted to give insertion products with low selectivity
(Scheme S3).
Site-Selective Insertions of Carbenes into Phthalan Derivatives
Catalyzed by Ir(Me)-containing CYP119
Two of the 21 mutant variants catalyzed the insertion
reaction of EDA into a series of 4-substituted phthalan
derivatives containing various functional groups with good
TONs and measurable chemo- and site selectivity for either
para or meta isomers. The reaction of 4-bromophthalan 1a
catalyzed by the mutant PG2 (PG1+D177N, H340L) gave
a 3.2:1 ratio of constitutional isomers in favor of the para
isomer with 1160 TON, while the same reaction catalyzed by
the mutantMG2 (MG1+A247S) gave a 1:3.4 ratio of isomers in
favor of the meta isomer with 1456 TON (Scheme 3). Similar
results were observed for reactions of 4-chlorophthalan 1b.
The reaction catalyzed by the mutant PG2 formed the product
from insertion into the benzylic C@H bond para to the chloro-
substituent as the major product with a 3.5:1 ratio of
constitutional isomers and 2286 TON, while the reaction
catalyzed by the mutant MG2 yielded the meta insertion
product in a 1:3.1 ratio and with 1380 TON.
Phthalan 1c contains a 4-tBu substituent, which is larger
than the halides of 1a and 1b. However, the site selectivity
values of reactions of this sterically distinct substrate with
CYP119 mutants were similar to those of reactions of 1a and
1b. The product from insertion into the benzylic C@H bond
para to the tBu substituent was favored by the mutant PG2 in
a ratio of 7.7:1 and accomplished with 130 TON. Although the
selectivity for the meta benzylic C@H bond of 1c from
reactions catalyzed by the mutant MG2 was lower than that for
reaction of 1a and 1b, the selectivity, nevertheless, was
reversed to 1:1.4 in favor of the meta isomer with up to 190
TON. Thus, we were able, again, to identify a pair of mutants
(PG2 and MG2) that react with nearly a > 10:1 reversal of site
selectivity between mutants for the two types of C@H bonds
present in 1c.
Nitro-substituted reactants rarely undergo C@H bond
functionalization, and the 4-nitro-substituted phthalan 1d
previously did not react with EDAwhen catalyzed by a small-
molecule iridium species.[12] However, the reaction of this
substrate with EDA catalyzed by an iridium-containing ArMs
Figure 1. Structure of WT Fe CYP119 (image prepared in Chimera from
PDB ID: 1IO7).[16] Red: mutant positions that were generated by site-
directed mutagenesis (A152, T213, V254, C317); orange: additional
positions generated by error-prone PCR for para selectivity (D177 and
H340) and meta selectivity (A247).
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formed the product from insertion into the C@H bond.
Although the turnover numbers from this reaction were lower
than those from reactions of other substrates, the reaction of
4-nitrophthalan 1d catalyzed by the mutant PG2 formed the
product from reaction of the benzylic C@H bond para to the
nitro substituent as the major isomer with a 5.6:1 ratio over
that from reaction at the C@H bond in the methylene group
meta to the nitro substituent (363 TON). The same reaction
catalyzed by the mutant MG2 preferentially formed the
product from reaction at the methylene C@H bond meta to
the nitro substituent with a 1:2.1 ratio of constitutional
isomers. A similar preference for reaction with the methylene
C@H bond para to the substituent was observed from the
reaction of 4-cyanophthalan 1e catalyzed by PG2 with a 9.9:1
ratio over the reaction at the methylene C@H bond meta to
the cyano substituent (181 TON). The selectivity was reversed
to 1:1.5 in favor of reaction at the benzylic C@H bondmeta to
the cyano substituent for the reaction catalyzed by the mutant
MG2 (531 TON), again demonstrating a 10:1 reversal of site
selectivity for a pair of mutant ArMs. Reaction of the 4-
iodophthalan 1 f also occurred with good selectivity for
insertion at the para position (3.1:1, 733 TON) when catalyzed
by the mutant PG2, whereas the same selectivity in favor of
reaction at the meta position (1:3.1) was observed for the
reaction catalyzed by mutant MG2 (1188 TON).
Substrates for which the Mutant Enzymes Selectively React at
the para C@H Bond
In addition to reacting site-selectively for one C@H bond
over another similar C@H bond, the ArMs we report
preferentially react with carbene insertion into benzylic C@
H bonds over other potential positions. The reaction of
amide-substituted phthalan 4a catalyzed by PG2 formed the
product from insertion of the carbene into the C@H bond with
17.8:1 selectivity for the benzylic C@Hbond para to the amide
substituent and 470 TON. No product from insertion of the
carbene into the N@H bond was observed from reactions
catalyzed by any of the Ir(Me)-bound CYP119 constructs.
Likewise, the products of the reactions of EDA with
amine-substituted phthalan 4b catalyzed by the free Ir(Me)-
porphyrin and artificial enzyme were distinct. The reaction of
EDAwith 4b catalyzed by Ir(Me)-MPIX gave products from
single and double carbene insertion into the C@H bond alpha
to nitrogen in the pyrrolidine. However, the reaction cata-
lyzed by the mutant PG2 occurred with high chemo- and site
selectivity for the C@H bond para to the amine substituent
(13.6:1 para selectivity and 55 TON).
The reactions of EDA with ester-substituted phthalan 4c
and ether-substituted phthalan 4d catalyzed by PG2 also
occurred with higher site selectivity compared to the reactions
catalyzed by free cofactor. The reaction catalyzed by Ir(Me)-
MPIX occurred with low TONs and almost no selectivity for
the methylene units para and meta to the ester- and ether
substituents (Scheme S3). However, selectivity of 8.3:1 was
observed for reaction at the methylene position para to the
ester substituent of 4c when catalyzed by the mutant PG2 (268
TON). The reaction of 4d occurred with 1796 TON and 6.4:1
selectivity for the methylene para to the methoxy substituent.
These reactions in Scheme 4, combined with the reactions of
cyano- and nitro-substituted phthalans in Scheme 3, illustrate
the potential of ArMs to enhance para-selectivity regardless
of the electron-donating properties of the substituents.
Enantioselective Intermolecular C@H Insertion Catalyzed by
Ir(Me) CYP119
Our results show that the environment within the ArMs
can control the number of insertion events and the site
selectivity of the atom-transfer, and it can confer tolerance of
several potentially reactive functional groups. We have shown
previously that C@H insertion reactions catalyzed by Ir(Me)
P450s can occur in an enantioselective fashion.[11] Because the
current work is focused on assessing the ability of ArMs to
catalyze reactions with site selectivity, we did not perform
extensive evolution to enhance enantioselectivity. Neverthe-
less, some of the reactions did occur with substantial
enantioselectivity when catalyzed by members of the mutant
library. For example, the reactions of EDA with 4-fluoroph-
thalan (7a) occurred to give the major constitutional isomer
in 97:3 er and the minor isomer in 92:8 er when catalyzed by
MG1+P252S (Scheme 5). The ratio of constitutional isomers
was 1:1.8 in favor of the meta isomer. Although this site
selectivity is lower than that of reactions of other substituted
Scheme 3. Scope of substrates for which the CYP119 mutants PG2 and
MG2 gave opposite site selectivity. TONs refers to the formation of
both meta and para benzylic C@H bond insertion products and were
determined by GC with dodecane as the internal stander. [a]
0.02 mol% Ir(Me)-MPIX CYP119 was used. [b] 0.1 mol% Ir(Me)-MPIX
CYP119 was used.
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phthalans, it does show that the enzyme can react with
significant site selectivity and enantioselectively for two C@H
bonds that differ only by a remote fluorine versus hydrogen
on the aryl ring. A fluorine atom has the closest size to
hydrogen of any atom, and has the closest Hammett
parameter to hydrogen of nearly any substituent.[15] In
comparison with our prior results from the reaction of
phthalan and EDA catalyzed by an Ir(Me) P450 (84:16 er,
324 TON),[11] higher enantioselectivity and reactivity was
observed from the same reaction catalyzed by the mutant
MG1+P252S (90:10 er and 1520 TON).
[6a] The feasibility of
this reaction on a synthetic scale was assessed by conducting
the reactions of 1a and 1b on a 0.3 mmol scale (Scheme 6).
The yields of isolated product and selectivity were similar to
those for reactions on a 3 microgram scale.
Stability of a Series of Ir(Me) P450 Mutants
The majority of the mutations (A152, T213, V254, and
C317) were located within the active site; however, some
mutations, especially those generated by error-prone PCR
(D177, H340, and A247), are located far from the active site
in both PG2 and MG2 (Figure 1). As noted previously in this
paper, these additional mutations appear to enhance the
stability of the Ir(Me)-bound P450 construct because they
have a larger influence on turnover number than on site
selectivity (Scheme 3 and 4). To assess this line of reasoning,
we evaluated the stability of the Ir(Me)-bound CYP119
construct to temperature and reaction components.
To assist our evaluation of the effect of the mutations
distal to the active site, we generated two mutants, Mmax
(MG2+D177N, H340L) and Pmax (PG2+A247S), which con-
tain all of the mutations peripheral to the active site in either
MG2 or PG2. Like PG1, Pmax catalyzed the reaction of 1a with
a similar site selectivity ratio of 3:1 in favor of the para isomer,
but the turnover number of the reaction catalyzed by Pmax
(1450 TON) was twice as high as that of the reaction catalyzed
by PG1 (720 TON; Figure 2). Likewise, the site selectivity of
the reaction catalyzed by Mmax was similar to that of the
reaction catalyzed by MG1 (1:2.7 for MG1 vs. 1:3.5 for Mmax),
but the TON of the reaction catalyzed by Mmax (1834 TON)
was more than three times higher than that of reactions
catalyzed by the parent MG1 mutant (580 TON) (Figure 2).
These results further support the conclusion that the muta-
tions resulting from error-prone PCR (177N, 340L and 247S)
stabilize Ir(Me) P450 during the course of the reaction.
Recently, it was reported that modification of the
protein scaffold during cyclopropanation of alkenes cata-
lyzed by repurposed heme enzymes and ArMs can occur by
carbene transfer into the amino acid residues of the host
protein.[10c,17a,b] Because Ir(Me)-MPIX is a highly active
catalyst for carbene transfers, we suspected that this modifi-
cation could limit the TON of the Ir(Me)-bound P450
construct and that these distal mutations might be retarding
this modification. However, masses corresponding to addition
of EDA to the protein or addition of the methyl group of the
Ir(Me) cofactor to the protein were not observed from
analysis of intact proteins by ESI-MS after addition of EDA
to the six mutants of Ir(Me)-PIX CYP119 that gave the
highest selectivity or addition of EDA and 4-bromophthalan
1a to the same six mutants.[17c] Instead, the carbene undergoes
rapid formation of fumarate and maleate (Figure S79).
Scheme 6. Scale-up the reactions catalyzed by mutant PG2.
Scheme 4. Scope of substrates for which mutant enzymes are selective
for reaction at the C@H bond in the methylene group para to the
substituent. TONs refer to the formation of products from insertion
into the C@H bond of the methylene unit both meta and para to the
substituent and were determined by GC with dodecane as the internal
stander.
Scheme 5. Enantioselective intermolecular C@H insertion catalyzed by
Ir(Me) CYP119. TONs refer to the formation of products from
insertion into the C@H bond of the methylene group both meta and
para to the substituent with dodecane as the internal stander. The er
values were determined by HPLC with a chiral column.
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Perhaps the high rate of dimerization prevents reaction of
the carbene unit with amino acid residues of the protein
scaffold.
Prior studies on repurposed and artificial metalloenzymes
for carbene transfer showed that the CD spectrum changed
upon exposure to EDA.[10c,17a] Thus, we measured the CD
spectra of PG1, PG2, Pmax, MG1, MG2, and MMax in the apo and in
the holo forms of Ir(Me) CYP119 before and after exposure
to EDA. The CD spectra are indistinguishable from each
other. No notable differences between the CD spectra of the
apo- and holo-CYP119 form were observed, or between the
CD spectra of these two proteins and that of the WT-CYP119
protein. The a-helicity ([q]222/[q]208) ratio was within 1.00 and
0.96 for all of the Ir(Me)-bound P450 constructs, and these
values are similar to those reported for the WT-CYP119
protein (Figures S60–S71).[18]
The melting temperatures (Tm) of a series of mutants were
measured by differential scanning calorimetry. No significant
differences among the Tm values of the mutants were
observed; the average Tm value was 67.5 8C with a standard
deviation of 0.2 8C among all the mutants (Table S2 and
Figures S84–S89). The reported Tm value of WT-CYP119 is
91.9 8C. It is not surprising that the Tm values of the mutants of
Ir(Me)-MPIX CYP119 are lower than that of WT-CYP119,
given the mutations and exchange of an axially ligated Fe-
heme cofactor for a non-ligated artificial Ir(Me)-MPIX
cofactor.[19] However, the similarity of the Tm values of the
mutants indicate that changes in the active site or in the
periphery of the protein have little effect on the folding and
thermal stability of the Ir(Me)-PIX CYP119. Therefore, the
higher TON of the systems containing peripheral mutations
seems to result from greater stability of the Ir(Me)-bound
P450 constructs during catalysis.
To probe the stability of CYP119s toward the reaction
components (substrate, product, solvent, etc.), Ir(Me)-bound
CYP119 mutants were treated with components of the
reaction mixture for one hour prior to initiating reactions
(Figures S55–59). This pretreatment of Ir(Me) CYP119s with
the reaction products influenced the selectivity of the
reaction. For example, reactions of 4-bromophthalan 1a with
EDA conducted after treating PG1 or MG1 with 4-chloroptha-
lan-product 2b for one hour occurred with negligible site
selectivity, whereas the same reaction conducted after treat-
ing Mmax or Pmax with 2b for one hour occurred with site-
selectivity ratios of 1:2 favoring the meta isomer and 1.8:1
favoring the para isomer, respectively (Figures S58,59). These
results imply that the peripheral mutations stabilize the
enzyme toward the C@H insertion products. This trend in
effect of product on selectivity is similar to the trend in
stability of the protein determined independently by CD
(Figures S79–S82). Although difficult to correlate quantita-
tively, we found that the concentrations of the proteins
containing peripheral mutations (Pmax and Mmax) were higher
than those of the parent mutants PG1 and MG1 after exposure
of equal concentrations of the Ir(Me)-bound P450 proteins to
acetate-substituted product 6c.[20]
Conclusion
In summary, artificial metalloenzymes containing a noble-
metal porphyrin (Ir(Me) CYP119) are capable of catalyzing
the intermolecular insertion of acceptor-only carbenes into
nearly equivalent C@H bonds with up to 17.8:1 site selectivity
for a series of 4-substitued phthalans. Through laboratory
evolution, a nearly 10:1 ratio between either themeta or para
constitutional isomers was obtained using two distinct Ir(Me)-
bound CYP119 mutants. Although not the primary focus of
this study, enantioselectivity of 97:3 can be obtained with the
current mutant library for the insertion of EDA into 4-
fluorophthalan. The insertion reactions catalyzed by the
Ir(Me) P450s tolerated a series of functional groups that have
not been tolerated by small-molecule catalysts for analogous
insertions of acceptor-only carbenes. Furthermore, unlike
other ArMs or repurposed heme enzymes, the Ir(Me) P450s
are less susceptible to deactivation from EDA insertion into
the protein framework. In general, this work highlights how
the combination of a highly active transition-metal active site
with a readily-evolvable protein framework can lead to
regioselectivities for abiotic reactions that would be difficult
to achieve with small-molecule catalysts.
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